Clive A. Meanwell
2012
In 2012, Clive A. Meanwell earned a total compensation of $6M as Chairman and Chief Executive Officer at Medicines, a 46% increase compared to previous year.
Compensation breakdown
| Bonus | $950,000 |
|---|---|
| Non-Equity Incentive Plan | $795,143 |
| Option Awards | $1,391,671 |
| Salary | $748,370 |
| Stock Awards | $2,066,250 |
| Other | $3,214 |
| Total | $5,954,648 |
Meanwell received $2.1M in stock awards, accounting for 35% of the total pay in 2012.
Meanwell also received $950K in bonus, $795.1K in non-equity incentive plan, $1.4M in option awards, $748.4K in salary and $3.2K in other compensation.
Rankings
In 2012, Clive A. Meanwell's compensation ranked 958th out of 11,487 executives tracked by ExecPay. In other words, Meanwell earned more than 91.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 958 out of 11,487 | 92nd |
Division Manufacturing | 348 out of 4,253 | 92nd |
Major group Chemicals And Allied Products | 78 out of 1,198 | 94th |
Industry group Drugs | 43 out of 920 | 95th |
Industry Pharmaceutical Preparations | 39 out of 700 | 94th |
Source: SEC filing on April 30, 2015.
Meanwell's colleagues
We found four more compensation records of executives who worked with Clive A. Meanwell at Medicines in 2012.